201. Neuroprotective Properties of Melatonin in a Model of Birth Asphyxia in the Spiny Mouse (Acomys cahirinus)
- Author
-
Hayley Dickinson, Lisa Cathleen Hutton, David Walker, Mahila Abbass, and Z. Ireland
- Subjects
Asphyxia ,Pregnancy ,biology ,Physiology ,Brain damage ,biology.organism_classification ,medicine.disease ,Neuroprotection ,Melatonin ,Developmental Neuroscience ,Neurology ,Spiny mouse ,Anesthesia ,medicine ,Gestation ,Precocial ,medicine.symptom ,medicine.drug - Abstract
Birth asphyxia is associated with disturbed development of the neonatal brain. In this study, we determined if low-dose melatonin (0.1 mg/kg/day), administered to the mother over 7 days at the end of pregnancy, could protect against the effects of birth asphyxia in a precocial species – the spiny mouse (Acomys cahirinus). At 37 days of gestation (term is 38–39 days), pups were subjected to birth asphyxia (7.5 min uterine ischemia) and compared to Cesarean section-delivered controls. At 24 h of age, birth asphyxia had increased markers of CNS inflammation (microglia, macrophage infiltration) and apoptosis (activated caspase-3, fractin) in cortical gray matter, which were reduced to control levels by prior maternal melatonin treatment. Melatonin may be an effective prophylactic agent for use in late pregnancy to protect against hypoxic-ischemic brain injury at birth.
- Published
- 2009